Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
A recent study revealed the hidden parallelisms in our organism’s response to cancer and COVID-19. Despite the marked differences between the two conditions, both seem to share a similar aberrant…
Phage display technology revolutionized antibody discovery. By coupling the structural simplicity of phages with the fast replication and high turnover… Read More
Ever since the onset of recombinant technology, therapeutic biologics production has gradually shifted from native to recombinant expression. Today, recombinant… Read More
Ever since the discovery of the hybridoma technology and its inherent limitations, monoclonal antibody production has gradually shifted from hybridoma-based… Read More
As more and more biotherapeutics enter the early stages of clinical development, scientists are questioning if current approaches will be… Read More
The emergence of the zoonotic pathogen, SARS-CoV-2, resulted in a global pandemic and caused the deaths of hundreds of thousands… Read More
Considered by many researchers as intermediate molecules, chimeric antibody constructs have been gradually losing ground to more effective molecules such… Read More
As the demand for fully human antibodies continues to rise, so does the proportion of clinical approvals of this type… Read More
For the first time, humanized and fully human antibodies are almost on equal terms. Up to 2019, 38 humanized antibodies… Read More
In recent years, rabbit monoclonal antibody production using phage display has been sought after by researchers and industry leaders… Read More